Sign Up Today and Learn More About Kytopen Stock
Invest in or calculate the value of your shares in Kytopen or other pre-IPO companies through EquityZen's platform.
Kytopen Stock
Kytopen develops genome engineering platforms that enable cell therapy research and manufacturing.
About Kytopen Stock
Founded
2017
Headquarters
Cambridge, MA, US
Industries
Apps, Software, Artificial Intelligence
Kytopen Press Mentions
Stay in the know about the latest news on Kytopen
Kytopen, T-CURX, and the Fraunhofer IZI Establish Center of Excellence to Develop Advanced, Non-viral Cell Therapies
prnewswire • Apr 30, 2026
Kytopen: Series B Investment To Scale Cell Therapy Manufacturing Platform
pulse2 • Apr 11, 2026
Kytopen Expands Commercialization Efforts and Board of Directors Following Series B Investment Led by Telegraph Hill Partners
prnewswire • Apr 07, 2026
Kytopen Closes Series B Funding
finsmes • Apr 07, 2026
TQ Therapeutics GmbH Enters into Technology Access Agreement with Kytopen
prnewswire • Dec 02, 2025
Kytopen Management
Leadership team at Kytopen
Co-Founder
Cullen Buie
CEO & Co-Founder
Paulo Garcia
Join now and verify your accreditation status to gain access to:
- Kytopen Current Valuation
- Kytopen Stock Price
- Kytopen Management
- Available deals in Kytopen and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Kytopen Cap Table and Funding History by Share Class and Liquidity Preferences
- Kytopen Revenue and Financials
- Kytopen Highlights
- Kytopen Business Model
- Kytopen Risk Factors
- Kytopen Research Report from SACRA Research
Trading Kytopen Stock
How to invest in Kytopen stock?
Accredited investors can buy pre-IPO stock in companies like Kytopen through EquityZen funds. These investments are made available by existing Kytopen shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Kytopen stock?
Shareholders can sell their Kytopen stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."